Project Grant F31NS139617
- This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will fund research to develop a novel cellular model for investigating amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The researchers will directly convert patient-derived fibroblasts into neurons, preserving the epigenetic age of the starting cells, in order to...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $2,001,864 to Harvard University to investigate the subcellular mechanisms underlying the selective vulnerability of specific neuron subtypes in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The researchers will quantitatively study the localization of RNA, proteins, and translational regulation in the synapses and soma of vulnerable corticospinal neurons (CSN) and...
- This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $1,138,538 to Mayo Clinic Jacksonville to expand research into the mechanisms underlying frontotemporal lobar degeneration (FTLD), which causes frontotemporal dementia (FTD) and is genetically linked to amyotrophic lateral sclerosis (ALS). The research aims to investigate key...
- This $438,606 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is supporting research at Northwestern University to establish novel human models that investigate the mechanistic interaction between neurotrauma and amyotrophic lateral sclerosis (ALS)/frontotemporal dementia (FTD). The research utilizes ALS/FTD patient-specific induced...
- This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will support research to identify genetic modifiers that contribute to phenotypic heterogeneity in the amyotrophic lateral sclerosis (ALS) - frontotemporal degeneration (FTD) spectrum. The $3,204,260 award to The Trustees of the University of Pennsylvania, effective August 1, 2025 through July 31,...
- This Project Grant award of $374,349 from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports the development and optimization of a new animal model for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The goal is to create a mouse model that accurately recapitulates the human disease spectrum by incorporating an acetylation-mimicking...
- This $3.6 million project grant from the National Institute on Aging, part of the Department of Health and Human Services, will fund research at the Icahn School of Medicine at Mount Sinai directed at understanding the role of glial cell interactions surrounding amyloid plaques in the progression of Alzheimer's disease. As part of the Aging Research program (CFDA 93.866), the three-year award will support investigation of how deletion of the Plexin-B1 gene impacts glial network formation and the...
- This $3,081,936 federal Project Grant award was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award supports research at the University of California, San Diego (UCSD) to investigate the mechanisms underlying TDP-43 proteinopathies, which are associated with amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), Alzheimer's disease,...
- This federal Project Grant award of $592,233.00 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will support research on the regulation of sphingolipid biosynthesis and its relationship to amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease. The research will utilize cellular models and mouse models to investigate how mutations in the serine...
- This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $236,668.00 to Cleveland Clinic Lerner College of Medicine of Case Western Reserve University to conduct research on the impact of the C9ORF72-associated poly (GR) protein on the structure and function of the BAF chromatin remodeling complex. The research aims to...
MICROGLIA- ASTROCYTE CROSSTALK IN CORTICAL NEURODEGENERATION OF C9ORF72 ALS/FTD - PROJECT ABSTRACT AMYOTROPHIC LATERAL SCLEROSIS (ALS) IS A PROGRESSIVE NEURODEGENERATIVE DISEASE CHARACTERIZED BY LOSS OF SPINAL CORD AND CORTICAL MOTOR NEURONS, AND FRONTOTEMPORAL DEMENTIA (FTD) IS AN EARLY-ONSET DEMENTIA SYNDROME CAUSED BY THE DEGENERATION OF THE FRONTAL AND TEMPORAL LOBES. THE MOST COMMON GENETIC CAUSE OF BOTH THESE DISEASES IS THE GGGGCC(G4C2) HEXANUCLEOTIDE REPEAT EXPANSION (HRE) IN THE FIRST INTRON OF THE C9ORF72. MUCH OF THE KNOWLEDGE IN C9ORF72-ALS/FTD DISEASE PATHOGENESIS THUS FAR HAS COME THROUGH INVESTIGATIONS OF NEURONAL DISEASE MECHANISMS. DESPITE THE LARGE EVIDENCE OF THE ACTIVE INVOLVEMENT OF GLIAL CELLS IN NEURODEGENERATION, LITTLE IS KNOWN ABOUT THE SPECIFIC MECHANISMS. ONE QUESTION THAT REMAINS UNANSWERED IS WHETHER A GLIA-GLIA INTERACTION IS REQUIRED TO INITIATE NEURODEGENERATION, OR DO ASTROCYTES AND MICROGLIA INDEPENDENTLY CONTRIBUTE TO THIS PROCESS? WE HAVE SHOWN AN ALTERED EXPRESSION PROFILE OF MICROGLIA AND ASTROCYTES IN THE FRONTAL CORTEX OF C9ORF72 ALS/FTD PATIENTS. ADDITIONALLY, IN OUR IPSC MODELING SYSTEM WE HAVE SEEN ABERRANT EXPRESSION OF THE NLRP3 INFLAMMASOME IN MICROGLIA AND ASTROCYTES. THESE FINDINGS LEAD TO THE FOLLOWING HYPOTHESIS: MICROGLIA- ASTROCYTE CROSSTALK UNDERLIES A CHRONIC PRO-INFLAMMATORY STATE IN C9ORF72 ALS/FTD. TO INVESTIGATE THIS KNOWLEDGE GAP, WE WILL UTILIZE STATE OF THE ART HUMAN IN VITRO CULTURE SYSTEMS, WHICH OFFER OPPORTUNITIES FOR EASY CELL-TYPE SPECIFIC MANIPULATIONS AND ANALYSES WHILE WORKING WITH HUMAN PATIENT-DERIVED CELLS. WE WILL UTILIZE MONO-CULTURE SYSTEMS TO ASSESS MORPHOLOGICAL, FUNCTIONAL, RNA, AND PROTEIN CHANGES. WE WILL VALIDATE OUR IN VITRO FINDINGS USING ALS/FTD PATIENT BRAIN TISSUES ON BOTH THE RNA AND PROTEIN LEVELS WITH THE INTENT OF UNDERSTANDING THE CELL-TO-CELL REGULATORY MECHANISMS OF GLIA AND THEIR CONTRIBUTION TO DISEASE PATHOLOGY. THESE STUDIES WILL PROVIDE NOVEL MOLECULAR TARGETS AND BIOMARKERS OF DISEASE.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 8/13/25 | ||
| Not listed | $45.7k | 8/13/25 |